IPP Bureau
Supriya Lifescience Q2 FY2023 profit slips to Rs. 16.86 Cr
By IPP Bureau - November 14, 2022
The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.
Biocon Biologics features on ASIA IP ELITE List 2022
By IPP Bureau - November 14, 2022
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
GSK India announces 9% sales growth across General Medicines and Specialty business
By IPP Bureau - November 14, 2022
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
Aurobindo Pharma Q2 FY23 revenue down 3.4%
By IPP Bureau - November 14, 2022
Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore
Alembic receives USFDA final approval for Cyclophosphamide Capsules
By IPP Bureau - November 14, 2022
Cyclophosphamide Capsules, 25 mg and 50 mg, have an estimated market size of US$ 8 million for twelve months ending Sep 2022 according to IQVIA.
Sanofi, GSK’s next-generation COVID-19 booster vaccine approved by the European Commission
By IPP Bureau - November 11, 2022
First and only next-generation protein-based adjuvanted COVID-19 booster approved in Europe
Jagsonpal Pharmaceuticals reports Q2FY23 net profit at Rs. 10.41 Cr
By IPP Bureau - November 11, 2022
The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022.
Pfizer and BioNTech receive positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster
By IPP Bureau - November 11, 2022
The European Commission will review the CHMP recommendation and is expected to make a final decision soon.
Biogen appoints Christopher Viehbacher as President and CEO
By IPP Bureau - November 11, 2022
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
YS Biopharma announces USFDA clearance of IND Application for PIKA COVID-19 vaccine
By IPP Bureau - November 11, 2022
PIKA COVID-19 vaccine is currently in Phase 3, multi-country, multi-center clinical trial conducted at Southeast Asian and Middle East countries.
Ayu Health receives US $27 million additional funding
By IPP Bureau - November 11, 2022
The company is making its entry into the Hyderabad market through its unique asset-light business model
IMPCL registers impressive threefold increase in profit for FY21-22
By IPP Bureau - November 11, 2022
The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Sonowal
Dr. Lucica Ditiu appreciates India's TB elimination response
By IPP Bureau - November 11, 2022
Dr. Mandaviya agreed to host the Stop TB Partnership’s 36th Board meeting on March 25-26, 2023 in Varanasi
Centre deploys high level team to Mumbai to take stock of Measles cases
By IPP Bureau - November 10, 2022
The team will assist the State Health Authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
ASG Eye Hospitals enters Haryana and expands footprint in UP
By IPP Bureau - November 10, 2022
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
